Category: Around the Industry

  • PCA Expands into Asia with Cigraal Partnership

    PCA Expands into Asia with Cigraal Partnership

    The Premium Cigar Association (PCA) announced a strategic partnership with Cigraal to expand its presence in Asia, aiming to support growth and professionalization of the premium cigar sector across key markets, the organization said in a press release. The collaboration will focus on education, regulatory advocacy, and industry engagement in the Asia-Pacific region, the Middle East, and Africa.

    The initiative will launch with PCA Connect Asia, a multi-city program scheduled for November 30 to December 6, featuring training workshops, certification programs and industry events in Hong Kong and Macau. The program will bring together retailers, hospitality operators and industry stakeholders through structured education and networking activities.

    PCA said the partnership reflects growing demand for premium cigars in Asia and the need for stronger industry frameworks to support that expansion. Cigraal, which operates across distribution, retail and brand development, will provide regional expertise to support the rollout of the program.

  • Illicit Cigarettes Undermine Health Warnings in New Zealand

    Illicit Cigarettes Undermine Health Warnings in New Zealand

    A Radio New Zealand investigation found black market cigarettes widely sold in Auckland without mandated health warnings, often at prices as low as NZ$13 ($7.67) per pack—less than a third of legal products. Under New Zealand law, tobacco packaging must carry graphic health warnings covering at least 75% of the pack, but most illicit products lack these labels, making enforcement more difficult for authorities.

    Public health experts say the absence of warnings and lower prices are undermining efforts to reduce smoking, particularly among low-income groups and young people. Officials note that non-compliant packaging is a key indicator used to identify illegal products, while penalties for violations include fines of up to NZ$600,000 ($354,000) for manufacturers and prison terms or fines for retailers.

  • Dutch Tobacco Revenues Decline Despite Tax Hikes

    Dutch Tobacco Revenues Decline Despite Tax Hikes

    Tobacco excise revenues in the Netherlands fell to €2.55 billion in 2025 from nearly €3 billion a year earlier, despite multiple tax increases, according to Statistics Netherlands. Cigarette excise duties have doubled since 2020, while taxes on smoking tobacco have more than tripled, pushing the minimum price of a pack of cigarettes to €7.81.

    The decline in revenue coincides with falling smoking rates and shifting consumer behavior. The share of smokers dropped from one in four in 2015 to one in six in 2025, while daily smoking also declined. At the same time, more consumers are purchasing tobacco abroad, with cross-border buying rising significantly, and vaping uptake increasing in recent years.

  • Greek Authorities Dismantle €1 Billion Illicit Cigarette Network

    Greek Authorities Dismantle €1 Billion Illicit Cigarette Network

    Greek authorities dismantled a large-scale illegal cigarette production and smuggling network accused of causing €1 billion in losses over eight years. The operation, led by the Hellenic Authority for Combating Money Laundering following a four-month investigation, resulted in the freezing of extensive assets, including 42 properties, a factory used for processing illicit cigarettes, 76 vessels, and dozens of vehicles.

    The case involves 38 individuals and 21 companies, with authorities identifying two alleged ringleaders and several accomplices connected to a broader family network. Investigators said the group used shell companies, fake invoices and false certifications to launder proceeds and conceal the scale of its operations.

  • Tasmania Passes Bill to Strengthen Crackdown on Illicit Tobacco and Vapes

    Tasmania Passes Bill to Strengthen Crackdown on Illicit Tobacco and Vapes

    Tasmania’s House of Assembly passed the Public Health Amendment (Prohibited Tobacco and Other Products) Bill 2026, introducing new offences, higher penalties, and expanded powers to shut down businesses involved in the illegal sale of tobacco and vaping products. The legislation targets illicit trade and aims to strengthen enforcement against unauthorized products.

    Health Minister Bridget Archer said the measures are intended to reduce smoking and prevent youth access, while Police Minister Felix Ellis linked the illicit market to organized crime, warning against the spread of related criminal activity. The bill will now move to the Legislative Council for further consideration.

  • Articles Accuse Makary of Putting Reputation Over Science

    Articles Accuse Makary of Putting Reputation Over Science

    Over the weekend, multiple sources criticized FDA Commissioner Marty Makary for being influenced by reputational considerations rather than evolving evidence on risk and consumer behavior in the regulation of reduced-harm nicotine products. According to The Wall Street Journal, tensions have emerged between the White House and the FDA, with the administration pushing to expand access to flavored vaping products while Makary has blocked authorizations despite internal scientific support. The report cited a case involving vape company Glas, where FDA scientists recommended approval of several flavors, but a memo from Makary’s office delayed the decision, highlighting a divergence between scientific review and agency leadership.

    Separately, Brownstone Institute published an article by Roger Bate arguing that regulatory progress on reduced-risk nicotine products has stalled despite declining youth vaping rates and evidence supporting harm reduction. Bate wrote that approvals for products such as vapes and nicotine pouches have slowed significantly, and wrote that “reputable sources” attributed this in part to Makary’s reluctance to act, citing concerns within the agency that decisions are being shaped by reputational risk rather than scientific data.

  • BAT Calls Pakistan Largest Illicit Cigarette Market

    BAT Calls Pakistan Largest Illicit Cigarette Market

    British American Tobacco (BAT) says Pakistan has become the world’s largest illicit cigarette market, with illegal products accounting for roughly 55–58% of consumption. Simon Trussler, BAT’s Group Head of International Trade and Fiscal Affairs, said steep tax increases in recent years have widened the price gap between legal and illicit cigarettes—now around half the price—driving consumers toward untaxed products while overall consumption remains broadly unchanged at about 80 billion sticks annually.

    BAT said higher taxes have failed to deliver expected revenue gains and instead have fueled domestic illicit production, which accounts for the majority of illegal supply. The company called for a more stable excise policy alongside sustained enforcement across the supply chain, noting recent seizures and factory closures as signs of increased government action.

  • Belgium Nearing 1 Billion Illicit Cigarettes Seized

    Belgium Nearing 1 Billion Illicit Cigarettes Seized

    Belgian authorities have seized 946 million counterfeit cigarettes between January 2020 and November 2025, resulting in an estimated €394 million in lost tax revenues, according to government data. In 2025 alone, customs confiscated nearly 150 million illegal cigarettes and uncovered multiple clandestine production and storage sites across the country, highlighting the scale of the illicit trade.

    Officials say the operations are driven by sophisticated, decentralized criminal networks that spread production and distribution across multiple locations to evade detection. Lawmakers are calling for stronger international cooperation, with Belgium already working alongside Europol and other agencies to disrupt cross-border supply chains.

  • PCA Honors Industry Leaders with 2026 Step Up Awards

    PCA Honors Industry Leaders with 2026 Step Up Awards

    The Premium Cigar Association (PCA) recognized a group of industry and policy leaders at its 2026 Trade Show in New Orleans, presenting its annual Step Up Awards for advocacy and leadership. Honorees included retailers, manufacturers, and policymakers such as Rocky Patel, Drew Estate’s Glenn Wolfson, and Louisiana Governor Jeff Landry, alongside local advocates credited with advancing cigar-friendly legislation and opposing tax increases.

    The awards highlight efforts across multiple states, including successful lobbying for cigar bar exemptions, tax caps, and the formation of new industry associations. PCA said the recipients reflect the growing importance of coordinated advocacy at local, state, and national levels as the premium cigar sector navigates evolving regulatory pressures.

  • FDA Renews Modified Status for IQOS Products

    FDA Renews Modified Status for IQOS Products

    The U.S. Food and Drug Administration has renewed modified risk tobacco product (MRTP) orders for several Philip Morris International IQOS devices and HeatSticks consumables, allowing the company to continue marketing the products with reduced-exposure claims. The authorization covers two IQOS device systems and three HeatStick variants, with the FDA reaffirming that available scientific evidence supports claims that switching completely from cigarettes to IQOS can significantly reduce exposure to harmful chemicals.

    The products receiving modified risk granted orders are IQOS 2.4 system, IQOS 3.0 system, Marlboro Amber HeatSticks (previously Marlboro HeatSticks), Marlboro Green Menthol HeatSticks (previously Marlboro Smooth Menthol HeatSticks), and Marlboro Blue Menthol HeatSticks (previously Marlboro Fresh Menthol HeatSticks).

    The agency said its latest review found new data consistent with earlier findings from initial approvals granted between 2019 and 2022. Under the renewed orders, Philip Morris can state that the IQOS system heats rather than burns tobacco, resulting in lower production of harmful substances. However, the FDA emphasized that the designation does not mean the products are safe or approved, and it restricts the company from making broader health or risk-reduction claims beyond those explicitly authorized.

    The renewed MRTP status is subject to ongoing regulatory oversight, including requirements for postmarket surveillance to monitor consumer behavior and public health impact. The FDA retains the authority to withdraw the authorization if the products no longer demonstrate a net benefit to population health.